Примери за използване на Fablyn на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
What FABLYN contains.
Before you take FABLYN 3.
FABLYN contains lactose.
Medication name Fablyn.
Why has Fablyn been approved?
There is no specific antidote for FABLYN.
FABLYN 500 microgram film-coated tablets.
INFORMATION FOR THE USER FABLYN 500 microgram film-coated tablets lasofoxifene.
Fablyn is intended for long-term use.
The most common side effect with Fablyn(seen in more than 1 patient in 10) is muscle cramps.
FABLYN increases risk of venous thromboembolism(VTE).
The European Commission granted a marketing authorisation valid throughout the European Union for Fablyn to Pfizer Limited on 24 February 2009.
FABLYN is only for use in postmenopausal women.
Patients may also receive calcium andvitamin D supplements if they do not get enough from their diet. Fablyn is intended for long-term use.
What FABLYN contains• The active substance is lasofoxifene.
The active substance in Fablyn, lasofoxifene, is a selective oestrogen receptor modulator(SERM).
FABLYN 500 microgram film-coated tablets lasofoxifene.
Over five years, 6% of the women taking Fablyn 500 micrograms had a new spine fracture(155 out of 2,748), compared with 9% of those taking placebo(255 out of 2,744).
FABLYN must not be taken during lactation(see section 4.3).
Fablyn is a medicine that contains the active substance lasofoxifene.
Fablyn(lasofoxifene tartrate)- Summary of product characteristics- G03.
Fablyn was more effective than placebo at reducing the number of new fractures.
Fablyn(lasofoxifene tartrate)- Conditions or restrictions regarding supply and use- G03.
FABLYN causes morphologic changes, particularly the cystic atrophy of endometrium.
Fablyn should be used with caution in women with severe liver or kidney problems.
Fablyn did not reduce the number of hip fractures to a level that would be relevant for patients.
Fablyn has been shown to reduce fractures in the spine and elsewhere in the body, but not in the hip.
Fablyn must not be used in people who are hypersensitive(allergic) to lasofoxifene or any of the other ingredients.
Fablyn should not be used in people who may be hypersensitive(allergic) to lasofoxifene or any of the other ingredients.
Fablyn is used for the treatment of osteoporosis(a disease that makes bones fragile) in postmenopausal women(women who have been through the menopause).